Sana Biotechnology, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Operating income | -$250.3 | -$272.7 | -$293.1 | -$272.6 | -$356.9 |
| Net income | -$244.2 | -$266.8 | -$283.3 | -$269.5 | -$355.9 |
| Cash Flow Statement | |||||
| Free cash flow | -$144.8 | -$256.6 | -$273.6 | -$310.9 | -$280.9 |
Shares outstanding 278.3M · Free float 68.7%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.